Cubist Systematic Strategies’s Fulcrum Therapeutics FULC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-57,070
| Closed | -$164K | – | 1829 |
|
|
2025
Q1 | $164K | Buy |
+57,070
| New | +$164K | ﹤0.01% | 1207 |
|
|
2024
Q2 | – | Sell |
-171,507
| Closed | -$1.62M | – | 1876 |
|
|
2024
Q1 | $1.62M | Buy |
+171,507
| New | +$1.62M | 0.01% | 958 |
|
|
2023
Q2 | – | Sell |
-65,076
| Closed | -$185K | – | 2535 |
|
|
2023
Q1 | $185K | Buy |
65,076
+34,374
| +112% | +$98K | ﹤0.01% | 2242 |
|
|
2022
Q4 | $224K | Sell |
30,702
-5,839
| -16% | -$42.5K | ﹤0.01% | 2591 |
|
|
2022
Q3 | $296K | Sell |
36,541
-216,513
| -86% | -$1.75M | ﹤0.01% | 2785 |
|
|
2022
Q2 | $1.24M | Buy |
253,054
+242,167
| +2,224% | +$1.19M | 0.01% | 1954 |
|
|
2022
Q1 | $257K | Sell |
10,887
-14,037
| -56% | -$331K | ﹤0.01% | 2902 |
|
|
2021
Q4 | $441K | Sell |
24,924
-5,574
| -18% | -$98.6K | ﹤0.01% | 2534 |
|
|
2021
Q3 | $860K | Buy |
30,498
+27,703
| +991% | +$781K | 0.01% | 1639 |
|
|
2021
Q2 | $29K | Sell |
2,795
-860
| -24% | -$8.92K | ﹤0.01% | 2832 |
|
|
2021
Q1 | $43K | Buy |
3,655
+3,110
| +571% | +$36.6K | ﹤0.01% | 2740 |
|
|
2020
Q4 | $6K | Buy |
+545
| New | +$6K | ﹤0.01% | 2523 |
|
|
2020
Q3 | – | Sell |
-200
| Closed | -$4K | – | 2534 |
|
|
2020
Q2 | $4K | Buy |
+200
| New | +$4K | ﹤0.01% | 2351 |
|